Compare SYK & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYK | UBS |
|---|---|---|
| Founded | 1941 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2B | 120.6B |
| IPO Year | N/A | N/A |
| Metric | SYK | UBS |
|---|---|---|
| Price | $358.54 | $48.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 2 |
| Target Price | ★ $434.19 | $60.30 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | 0.99% | ★ 1.56% |
| EPS Growth | N/A | ★ 84.33 |
| EPS | ★ 7.61 | 2.21 |
| Revenue | $24,381,000,000.00 | ★ $48,193,000,000.00 |
| Revenue This Year | $12.01 | $5.16 |
| Revenue Next Year | $8.61 | $3.74 |
| P/E Ratio | $46.65 | ★ $20.36 |
| Revenue Growth | ★ 10.95 | 2.09 |
| 52 Week Low | $329.16 | $25.75 |
| 52 Week High | $406.19 | $48.43 |
| Indicator | SYK | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 65.19 |
| Support Level | $350.83 | $46.60 |
| Resistance Level | $365.30 | $48.26 |
| Average True Range (ATR) | 7.55 | 0.57 |
| MACD | -0.32 | -0.22 |
| Stochastic Oscillator | 36.54 | 83.70 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.